Overview

A Study of Intravenous (IV) Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients

Status:
Not yet recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, pediatric trial of amisulpride for prophylaxis of post operative nausea and vomiting
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Acacia Pharma Ltd
Collaborators:
Amicus CD LLC
Premier Research Group plc
Treatments:
Amisulpride
Dexamethasone
Ondansetron